Chase AIPricingFAQs
Display currency
Loading news…

ImmunityBio

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Culver City, California, United States Founded 2014 501-1000 employees For Profit

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
3
Monthly Visits
Available in Pro
Contacts
401
Ticker
IBRX
NASDAQ
Patents
143
94 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
IBRX
Exchange
NASDAQ
IPO date
Mar 10, 2021
Valuation range
$1B to $10B

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
11
Active products
18
Patents granted
143
Trademarks
94
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$1.79M

Company Info

Founded
2014
Employees
501-1000
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
640
HQ
Culver City, California, United States
Region
Greater Los Angeles Area, West Coast, Western US
Exit date
Mar 10, 2021

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-1.3
Trend (30d)
-3.4
Trend (90d)
-5.2
Last leadership hire
Aug 3, 2023
Last layoff mention
Jan 31, 2025

Acquisitions by ImmunityBio

Loading columns…
0 of 0Show
Page 1 / 1

Key People at ImmunityBio

Chief Operating Officer
Chief Communications Officer
Senior Corporate Development Counsel
Chief Scientific Officer
Chief Medical Officer
Chief Strategy Officer
Director & Chief Corporate Affairs Officer
Chief Technology Officer
401
professional contacts at ImmunityBio
Contact execs at ImmunityBio

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to ImmunityBio

Loading news…

FAQs about ImmunityBio

People who checked this page also checked these

Browse the full Acquirezy directory.